Home » Newsletters » BioWorld Science

BioWorld Science

May 15, 1997

View Archived Issues

ET antagonists from Warner-Lambert claimed for cerebrovascular disorders

MS&D describes tachykinin antagonists

Factor Xa inhibitors from 3-D

Antiischemic potassium channel activators described by BMS

3-D describes potent and selective thrombin inhibitors

MS&D discloses 5-HT1-like receptor agonists

Glutamate antagonists from Warner-Lambert

Pharmacokinetics and tissue distribution of TOP-53

Nippon Shinyaku characterizes novel sulfonamide antitumor agent

Phase I/II results for Glaxo's tucaresol in metastatic melanoma

FDA approves Columbia's Crinone

PAK-104P reverses both P-glycoprotein- and MRP-mediated MDR

Potent, selective, orally active tachykinin NK1 antagonist reported by Menarini

New hypoxic cytotoxin from Evanston Hospital

Cellegy: Q1 1997 highlights

Interneuron: Q2 1997 highlights

Connetics: Q1 1997 highlights

NeoRx: Q1 1997 highlights

Dusa: Q1 1997 highlights

FDA advisory committee recommends Roche's Xenical for weight loss

Cytogen updates stockholders

Elan to market Dainippon's zonisamide in North America

SmithKline Beechan to market Kissei's tranilast

Discovery licenses N-0923 transdermal patch to Yoshitomi

NeoPharm licenses broxuridine to BioChem Therapeutic

Innovative Technologies and Derma Sciences form strategic joint venture

Receptagen receives offer to merge from Generex

Cephalon and Chiron seek European approval of Myotrophin

BMS and RTI form anticancer alliance

Mouse model for idiopathic voiding disorders in humans

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...